The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.

BioNTech SE ADR closed $17.54 below its 52-week high ($131.49), which the company reached on September 17th.

Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the National Institutes of Health and University of Pennsylvania ...

In Review 805 articles and counting2,837 new Instagram followers1,771 new Bluesky followers It was quite a year. Join us in ...

The World Health Organization estimates that nearly 15 million people were killed either by the new coronavirus or by its impact on overwhelmed health systems during the first two years of the ...

Super Micro stock declines, Nvidia trades lower, and MicroStrategy shares extend losses after a sharp drop in the previous ...

The Houthis, an Iranian-backed group based in Yemen, have launched repeated attacks despite the Israeli military’s retaliatory airstrikes. By Adam Rasgon Stepped up attacks by Russia are ...

New York Judge Delays Start of Trial Between CFTC and Gemini Trust Company ...